Chlamydia clinical trials at University of California Health

2 in progress, 0 open to eligible people

Showing trials for

  • Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections

    Sorry, not yet accepting patients

    The goal of this open-label, randomized trial is to assess the efficacy of doxycycline prophylaxis in reducing incidences of bacterial sexually transmitted infections (STIs) among people who were assigned female at birth (AFAB) while also evaluating acceptability and antimicrobial resistance in order to inform public health policy.

    at UCLA

  • Inflammation in Methamphetamine and STIs (IMSTI)

    Sorry, in progress, not accepting new patients

    This clinical trial aims to investigate the effects of a decline in methamphetamine use on rectal inflammatory cytokine levels, substance use contexts, and HIV/STI risk behavior. This clinical trial also seeks to evaluate joint effects of methamphetamine use and rectal gonorrhea/chlamydia infection on rectal inflammatory cytokine levels. The proposed trial will consist of 40 MSM, half with rectal gonorrhea/chlamydia infection at enrollment (n=20), with methamphetamine use disorder that will receive contingency management for methamphetamine reduction. Following baseline measurement, participants will be observed over the course of 8 weeks, where participants will complete behavioral surveys, provide urine for drug testing, and rectal samples for measurement of rectal inflammatory cytokine levels.

    at UCLA

Our lead scientists for Chlamydia research studies include .

Last updated: